These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12425830)

  • 1. [The effect and mechanism of felodipine on monocrotaline induced pulmonary hypertension in rats].
    Zeng Z; Huang H; Li X
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):461-4. PubMed ID: 12425830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
    Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
    Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats.
    Chang CY; Shih HJ; Huang IT; Tsai PS; Chen KY; Huang CJ
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium channel antagonists and pertussis toxin on noradrenaline-induced contractions in pulmonary artery from pulmonary hypertensive rats.
    Tabrizchi R; MacNicol BJ; Lin BP
    Life Sci; 1995; 56(14):1173-85. PubMed ID: 7475894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased relaxation by felodipine on pulmonary artery from rats with monocrotaline-induced pulmonary hypertension does not reflect functional impairment of the endothelium.
    Wanstall JC; O'Donnell SR; Kay CS
    Pulm Pharmacol; 1991; 4(1):60-6. PubMed ID: 1804496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of DCDDP, a calcium channel blocker, on chronic pulmonary hypertension in rat.
    Li ZC; Zhang FQ; Song JC; Mei QB; Zhao DH
    J Appl Physiol (1985); 2002 Mar; 92(3):997-1003. PubMed ID: 11842032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Li J; Long C; Cui W; Wang H
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):60-9. PubMed ID: 22947433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
    Suzuki R; Maehara R; Kobuchi S; Tanaka R; Ohkita M; Matsumura Y
    Life Sci; 2012 Oct; 91(13-14):693-8. PubMed ID: 22542556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R; Zeballos GA; Tun H; Gewitz MH
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.
    Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Rocha Nde N; Ferraz EB; do Nascimento JH; Sudo RT; Zapata-Sudo G
    Eur J Pharmacol; 2013 Feb; 702(1-3):316-22. PubMed ID: 23399770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
    Kodama K; Adachi H
    J Pharmacol Exp Ther; 1999 Aug; 290(2):748-52. PubMed ID: 10411587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
    Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
    Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Nagai R
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.